KALVISTA PHARMACEUTICALS INC (KALV) Stock Cash Flow
NASDAQ:KALV - Nasdaq - US4834971032 - Common Stock - Currency: USD
| TTM (2024-10-31) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -156.38M | -126.64M | -92.91M | -82.34M | -46.24M | |||
| Depreciation Amortization | 877.00K | 816.00K | 720.00K | 560.00K | 540.00K | |||
| Change In Working Capital | 13.48M | 15.17M | 7.41M | -12.32M | 8.35M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 19.49M | 21.43M | 9.52M | 15.96M | 7.19M | |||
| OPERATING CASH FLOW | -122.54M | -89.23M | -75.26M | -78.13M | -30.17M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -519.00K | -443.00K | -1.20M | -930.00K | -80.00K | |||
| Other Investing Activity | -46.53M | -84.28M | 42.61M | 58.79M | -147.57M | |||
| INVESTING CASH FLOW | -47.05M | -84.72M | 41.42M | 57.86M | -147.65M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | N/A | |||
| Stock Issued/Repurchased | 153.68M | 150.71M | 58.12M | 1.58M | 212.12M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 153.68M | 150.71M | 58.12M | 1.58M | 212.12M | |||
| Exchange Rate Effect | -171.00K | -1.21M | 1.24M | -1.17M | 510.00K | |||
| CHANGE IN CASH | -16.08M | -24.45M | 25.52M | -19.86M | 34.81M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -122.54M | -89.23M | -75.26M | -78.13M | -30.17M | |||
| Capital Expenditure | -519.00K | -443.00K | -1.20M | -930.00K | -80.00K | |||
| FREE CASH FLOW | -123.06M | -89.67M | -76.46M | -79.06M | -30.25M | |||
All data in USD